PTEN silencing reverses aging-related impairment of angiogenesis in microvascular endothelial cells

Andrzej S Tarnawski1, Rama Pai, Tetsuya Tanigawa

  • 1Medical Service, VALBHS and Department of Medicine, University of California Irvine, Long Beach, CA 90822, USA. atarnawski@yahoo.com

Insights

Aging impairs new blood vessel formation due to increased PTEN protein in endothelial cells. Reducing PTEN levels in aged cells restores normal angiogenesis, revealing a key mechanism in aging vascular health.

Area of Science:

  • Vascular Biology
  • Cellular Aging
  • Molecular Mechanisms of Aging

Background:

  • Aging is linked to reduced angiogenesis, the formation of new blood vessels.
  • The precise molecular causes of age-related angiogenesis impairment remain unclear.
  • PTEN (Phosphatase and Tensin homolog) is a phosphatase that negatively regulates the PI3K/Akt pathway, crucial for cell survival and angiogenesis.

Purpose of the Study:

  • To investigate the role of PTEN expression in endothelial cells in age-related angiogenesis impairment.
  • To determine if elevated PTEN contributes to the reduced ability of aged cells to form new blood vessels.

Main Methods:

  • Compared PTEN mRNA and protein levels in human microvascular endothelial cells (HMVEC) from aging and neonatal donors.
  • Assessed in vitro angiogenesis capacity of Aged-HMVEC versus neonatal HMVEC (Neo-HMVEC).
  • Utilized small interfering RNA (siRNA) to downregulate PTEN expression in Aged-HMVEC.

Main Results:

  • Aged-HMVEC exhibited significantly higher PTEN mRNA and protein levels compared to Neo-HMVEC.
  • Aged-HMVEC demonstrated impaired in vitro angiogenesis.
  • Downregulation of PTEN in Aged-HMVEC using siRNA restored their angiogenic capacity to levels comparable to Neo-HMVEC.

Conclusions:

  • This study provides the first evidence of increased PTEN expression in microvascular endothelial cells from aging human tissues.
  • Elevated PTEN levels are identified as a major contributing factor to the impairment of in vitro angiogenesis observed in aging.
  • Targeting PTEN may offer a therapeutic strategy to counteract age-related vascular dysfunction.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...